Songling Xuemaikang Capsule
Shop NowOverview
What is Songling Xuemaikang Capsule?
Songling Xuemaikang Capsule is a 3-ingredient proprietary Traditional Chinese Medicine (TCM) formula primarily used to manage hypertension and primary hyperlipidemia associated with liver yang hyperactivity in Traditional Chinese Medicine.
Product Information
| Chinese name | 松龄血脉康胶囊 |
|---|---|
| Alternative Name | Songling Xuemaikang Jiaonang |
| Brand | Jishengtang |
| Manufacturer | Sichuan Jishengtang Pharmaceutical Co., Ltd. |
| China Drug Approval No. | Z10960023 |
| Dosage form | capsule |
| Strength | 0.5 g per capsule |
| Individual package | 0.5 g × 60 capsules |
| GTIN | 10960023 |
| Prescription Status in China | Prescription medicine. |
Benefits & Uses
Benefits & Common Uses
Songling Xuemaikang Capsule is commonly used for:
- High blood pressure
- Primary hyperlipidemia
- Headache and dizziness
- Palpitations
- Irritability and insomnia associated with the indicated TCM pattern
Traditional Functions & Uses
平肝潜阳，镇心安神
Calm rising liver yang and settle the mind.
- Headache, dizziness, irritability, palpitations, and insomnia associated with rising liver yang.
- Hypertension or primary hyperlipidemia when the same labeled presentation is present.
Traditional-use wording does not replace diagnosis or individualized hypertension and lipid management.
The label frames use within the traditional pattern of rising liver yang. This is a traditional pattern, not a biomedical diagnosis.
Songling Xuemaikang Capsule is classified as a prescription medicine in China. This Learn information is for educational purposes only. Always consult a healthcare provider before starting TCM treatments.
Safety
Adverse Reactions
- Occasional mild diarrhea or stomach fullness may occur.
Contraindications
- Do not use if allergic to this product or any listed ingredient.
Precautions
Product-specific pregnancy information was not identified; seek professional advice if relevant.
Product-specific breastfeeding information was not identified.
Product-specific pediatric information was not identified.
Consult a clinician or pharmacist before combining it with other blood-pressure or lipid medicines.
Product-specific contraindications were reported as not clearly established in the reviewed information.
Taking the product after meals may help reduce these symptoms.
Evidence
Evidence at a Glance
Human studies include a 2025 placebo-controlled trial, an earlier systematic review, and a small combination-treatment trial, with limits on duration, population, and monotherapy interpretation.
Songling Xuemaikang capsule for grade 1 hypertension at low-to-moderate risk: a multicenter randomized placebo-controlled trial
A 9-center trial randomized 393 participants after a run-in phase; 356 entered the final analysis. After 8 weeks, SXC reduced 24-hour ambulatory SBP and DBP more than placebo, with no significant difference in adverse-event rates.
View More
Reported findings
A 9-center trial randomized 393 participants after a run-in phase; 356 entered the final analysis. After 8 weeks, SXC reduced 24-hour ambulatory SBP and DBP more than placebo, with no significant difference in adverse-event rates.
Limitations
The population was selected grade 1 hypertension with low-to-moderate cardiovascular risk and follow-up was 8 weeks; results do not establish suitability for every patient or long-term outcomes.
Songling Xuemaikang capsule for grade 1 hypertension at low-to-moderate risk: a multicenter randomized placebo-controlled trial.
Year: 2025
Study type: multicenter randomized double-blind placebo-controlled trial
PMID: 41075522
Songling Xuemaikang Capsule for primary hypertension: A systematic review of randomized controlled trials
The review evaluated randomized trials of SXC for primary hypertension and assessed effectiveness and safety.
View More
Reported findings
The review evaluated randomized trials of SXC for primary hypertension and assessed effectiveness and safety.
Limitations
The review searched through February 2013 and included heterogeneous trials; pooled evidence cannot authenticate every commercial package or replace current hypertension care.
Songling Xuemaikang Capsule for primary hypertension: A systematic review of randomized controlled trials.
Year: 2015
Study type: systematic review and meta-analysis of randomized controlled trials
PMID: 24584755
Effects of Songling Xuemaikang Capsule on ambulatory blood pressure in treatment of essential hypertension: a single-blind randomized controlled trial
A 70-patient study evaluated SXC added to routine antihypertensive treatment for 2 weeks and reported greater ambulatory blood-pressure reductions than routine treatment alone.
View More
Reported findings
A 70-patient study evaluated SXC added to routine antihypertensive treatment for 2 weeks and reported greater ambulatory blood-pressure reductions than routine treatment alone.
Limitations
The study was small, short, single-blind, and evaluated combination treatment rather than SXC monotherapy.
Effects of Songling Xuemaikang Capsule on ambulatory blood pressure in treatment of essential hypertension: a single-blind randomized controlled trial.
Year: 2009
PMID: 19583930
DOI: 10.3736/jcim20090603
Verification
- Brand relationship confirmed
- Manufacturer legal name confirmed
- Approval number confirmed
- Current packaging matched
- Registration holder / manufacturer checked
- Authenticity method checked
- Label/source evidence recorded
Official Label Dosage
Take 3 capsules and three times daily
A purchase option’s quantity does not define how long you should take the medicine.
Frequently Asked Questions About Songling Xuemaikang Capsule
It is labeled for headache, dizziness, irritability, palpitations, and insomnia associated with rising liver yang, and for hypertension or primary hyperlipidemia when that presentation is present.
The reviewed label states 3 capsules by mouth, 3 times daily, or as directed by a clinician.
Yes. Human studies include a 2025 placebo-controlled trial, a systematic review, and an earlier add-on trial; their populations and designs differ.
No. Persistent or elevated blood pressure needs individualized medical assessment and monitoring.
The reviewed information reports occasional mild diarrhea or stomach fullness and notes that taking it after meals may help.
Rising liver yang is a traditional pattern description, not a biomedical diagnosis.